Morgan Bradley Paul 4

Accession 0001061983-17-000052

CIK 0001061983other

View on SEC.gov Company Profile

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 7:20 PM ET

Size

77.7 KB

Accession

0001061983-17-000052

Insider Transaction Report

Form 4

Period: 2017-08-31

CYTOKINETICS INCCYTK

Morgan Bradley Paul

SVP Drug Discovery & Early Dev

Transactions

Sale
Common Stock
2017-08-31$15.00/sh−13,448$201,720→ 46,441 total
Sale
Common Stock
2017-08-31$15.00/sh−15,206$228,090→ 46,441 total
Exercise/Conversion
Common Stock
2017-08-31$11.10/sh+2,638$29,282→ 49,079 total
Exercise/Conversion
Common Stock
2017-08-31$11.10/sh+695$7,715→ 47,136 total
Exercise/Conversion
Common Stock
2017-08-31$9.65/sh+11,552$111,477→ 57,993 total
Sale
Common Stock
2017-08-31$15.00/sh−16,666$249,990→ 46,441 total
Exercise/Conversion
Common Stock
2017-08-31$9.65/sh+13,448$129,773→ 59,889 total
Exercise/Conversion
Common Stock
2017-08-31$6.67/sh+16,666$111,162→ 63,107 total
Sale
Common Stock
2017-08-31$15.00/sh−13,920$208,800→ 46,441 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2017-08-31−2,294→ 8,750 total
Exercise: $7.96From: 2015-03-26Exp: 2025-02-26→ Common Stock (2,294 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2017-08-31−13,448→ 5,000 total
Exercise: $9.65From: 2014-03-24Exp: 2024-02-24→ Common Stock (13,448 underlying)
Exercise/Conversion
Common Stock
2017-08-31$6.30/sh+13,920$87,696→ 60,361 total
Sale
Common Stock
2017-08-31$15.00/sh−617$9,255→ 46,441 total
Sale
Common Stock
2017-08-31$15.00/sh−11,552$173,280→ 46,441 total
Sale
Common Stock
2017-08-31$15.00/sh−21,204$318,060→ 46,441 total
Sale
Common Stock
2017-08-31$15.00/sh−1,079$16,185→ 46,441 total
Exercise/Conversion
Common Stock
2017-08-31$9.42/sh+617$5,812→ 47,058 total
Exercise/Conversion
Common Stock
2017-08-31$11.10/sh+2,639$29,293→ 49,080 total
Sale
Common Stock
2017-08-31$15.00/sh−11,883$178,245→ 46,441 total
Exercise/Conversion
Common Stock
2017-08-31$7.96/sh+2,294$18,260→ 48,735 total
Exercise/Conversion
Common Stock
2017-08-31$6.00/sh+21,204$127,224→ 67,645 total
Sale
Common Stock
2017-08-31$15.00/sh−3,795$56,925→ 46,441 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2017-08-31−21,204→ 0 total
Exercise: $6.00From: 2013-04-05Exp: 2023-03-05→ Common Stock (21,204 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-08-31−11,552→ 0 total
Exercise: $9.65From: 2014-03-24Exp: 2024-02-24→ Common Stock (11,552 underlying)
Sale
Common Stock
2017-08-31$15.00/sh−2,294$34,410→ 46,441 total
Sale
Common Stock
2017-08-31$15.00/sh−2,638$39,570→ 46,441 total
Exercise/Conversion
Incentive Stock Option (right to buy)
2017-08-31−2,638→ 0 total
Exercise: $11.10From: 2009-03-26Exp: 2019-02-26→ Common Stock (2,638 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-08-31−617→ 0 total
Exercise: $9.42From: 2011-03-28Exp: 2021-02-28→ Common Stock (617 underlying)
Exercise/Conversion
Common Stock
2017-08-31$7.96/sh+15,206$121,040→ 61,647 total
Exercise/Conversion
Common Stock
2017-08-31$6.00/sh+3,795$22,770→ 50,236 total
Exercise/Conversion
Common Stock
2017-08-31$6.30/sh+1,079$6,798→ 47,520 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-08-31−1,079→ 0 total
Exercise: $6.30From: 2012-04-05Exp: 2022-03-05→ Common Stock (1,079 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-08-31−695→ 0 total
Exercise: $11.10From: 2009-03-26Exp: 2019-02-26→ Common Stock (695 underlying)
Sale
Common Stock
2017-08-31$15.00/sh−694$10,410→ 46,441 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-08-31−694→ 695 total
Exercise: $11.10From: 2009-03-26Exp: 2019-02-26→ Common Stock (694 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2017-08-31−13,920→ 0 total
Exercise: $6.30From: 2012-04-05Exp: 2022-03-05→ Common Stock (13,920 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2017-08-31−11,883→ 0 total
Exercise: $9.42From: 2011-03-28Exp: 2021-02-28→ Common Stock (11,883 underlying)
Exercise/Conversion
Common Stock
2017-08-31$9.42/sh+11,883$111,938→ 58,324 total
Exercise/Conversion
Common Stock
2017-08-31$11.10/sh+694$7,703→ 47,135 total
Sale
Common Stock
2017-08-31$15.00/sh−2,639$39,585→ 46,441 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-08-31−3,795→ 0 total
Exercise: $6.00From: 2013-04-05Exp: 2023-03-05→ Common Stock (3,795 underlying)
Sale
Common Stock
2017-08-31$15.00/sh−695$10,425→ 46,441 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-08-31−15,206→ 3,750 total
Exercise: $7.96From: 2015-03-26Exp: 2025-02-26→ Common Stock (15,206 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2017-08-31−2,639→ 2,638 total
Exercise: $11.10From: 2009-03-26Exp: 2019-02-26→ Common Stock (2,639 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2017-08-31−16,666→ 14,517 total
Exercise: $6.67From: 2016-03-23Exp: 2026-02-23→ Common Stock (16,666 underlying)

Footnotes (2)

[F1]The exercise(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017.
[F2]The sale(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017.

Documents

2 files

Issuer

CYTOKINETICS INC

CIK 0001061983

→

Entity typeother

Related Parties

filerCIK 0001659025

Filing Metadata

Form type: 4
Filed: Aug 31, 8:00 PM ET
Accepted: Sep 1, 7:20 PM ET
Size: 77.7 KB

View on SEC.gov